No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DVA DaVita
- 134.750
- -3.940-2.84%
Close May 22 16:00 ET
- 139.854
- +5.104+3.79%
Post 18:11 ET
11.82BMarket Cap15.28P/E (TTM)
138.700High134.730Low933.69KVolume138.010Open138.690Pre Close126.77MTurnover1.94%Turnover Ratio18.16P/E (Static)87.70MShares145.04052wk High12.76P/B6.48BFloat Cap71.51052wk Low--Dividend TTM48.08MShs Float145.040Historical High--Div YieldTTM2.86%Amplitude0.687Historical Low135.777Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
Reasons to Add HealthEquity (HQY) Stock to Your Portfolio
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Comments
DaVita's global expansion strategy, backed by strong local team investment, is set to make a lasting impact on healthcare communities. Their focus remains on providing exceptional care for kidney disease patients.
Press Release: DaVita Enters Into Agreement to Expand Operations in Brazil and Colombia, Enter Chile and Ecuador 1
Legendary INvestor Warrent BUffett Portfolio
$Apple(AAPL.US$ $Bank of America(BAC.US$ $American Express(AXP.US$ $Coca-Cola(KO.US$ $CHERVON(02285.HK$ $The Kraft Heinz(KHC.US$ $Moody's(MCO.US$ $DaVita(DVA.US$ $CITIC BANK(00998.HK$
$Apple(AAPL.US$ $Bank of America(BAC.US$ $American Express(AXP.US$ $Coca-Cola(KO.US$ $CHERVON(02285.HK$ $The Kraft Heinz(KHC.US$ $Moody's(MCO.US$ $DaVita(DVA.US$ $CITIC BANK(00998.HK$
5
Analysts believe DaVita's strong Q4 financials and full-year outlook were driven by expected volume improvements and continued strong cost controls. However, some analysts maintain a cautious stance, waiting to see more proof points on volume improvement.
1
DaVita's shares are a bargain per the price multiple model. High beta indicates a potential fall in a bearish market, offering a prime buying opportunity. Expected profit growth promises a bright future, leading to higher cash flow and share valuation.
DaVita's current P/E ratio implies investors doubt the company's future growth prospects. Unobserved earnings threats may be hindering the positive outlook typically reflected in the P/E ratio.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
